|
You are here |
www.medicare.gov | ||
| | | | |
aspe.hhs.gov
|
|
| | | | | Insulin prices have increased dramatically over the past decade in the United States. This report presents results from international price comparisons of insulins using a price index approach. The average gross manufacturer price for a standard unit of insulin in 2018 was more than ten times the price in a sample of 32 foreign countries:$98.70 in the U.S., compared with $8.81 in the 32 non-U.S. OECD countries for which we have prescription drug data. The U.S. prices for the mix of insulin used in the U.... | |
| | | | |
www.healthcare-economist.com
|
|
| | | | | [AI summary] An analysis of various Centers for Medicare & Medicaid Innovation (CMMI) payment models proposed to reduce pharmaceutical costs and out-of-pocket expenses for beneficiaries, evaluating their mixed history of implementation and success. | |
| | | | |
www.costcurvenews.com
|
|
| | | | | It's inauguration day today, and I have no great insights on what is to come from a health policy POV. So I will repeat my standard mantra/gif about what's next: "Nobody knows." That will cease to be true at some point soon -- governing requires decisions -- but for now, I'm sticking with a shrug. | |
| | | | |
dissidentvoice.org
|
|
| | | The U.S. arms and supports Israel's genocide and one of its largest banks, Citibank, plays a key role. Our latest visual in partnership with the Banking on Solidarity campaign illustrates how Citi helps arm Israel, finances weapons companies that make the weapons Israel uses in Gaza, and invests in the Israeli financial and tech sectors. | ||